0000899243-19-026639.txt : 20191105 0000899243-19-026639.hdr.sgml : 20191105 20191105060843 ACCESSION NUMBER: 0000899243-19-026639 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191104 FILED AS OF DATE: 20191105 DATE AS OF CHANGE: 20191105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Snisarenko John CENTRAL INDEX KEY: 0001783264 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39112 FILM NUMBER: 191191639 MAIL ADDRESS: STREET 1: C/O ALIMERA SCIENCES, INC. STREET 2: 6120 WINDWARD PARKWAY, SUITE 290 CITY: ALPHARETTA STATE: GA ZIP: 30005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oyster Point Pharma, Inc. CENTRAL INDEX KEY: 0001720725 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 811030955 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 202 CARNEGIE CENTER STREET 2: SUITE 109 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: (609) 382-9032 MAIL ADDRESS: STREET 1: 202 CARNEGIE CENTER STREET 2: SUITE 109 CITY: PRINCETON STATE: NJ ZIP: 08540 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-11-04 0 0001720725 Oyster Point Pharma, Inc. OYST 0001783264 Snisarenko John C/O OYSTER POINT PHARMA, INC. 202 CARNEGIE CENTER, SUITE 109 PRINCETON NJ 08540 0 1 0 0 Chief Commercial Officer Common Stock, par value $0.001 per share 2019-11-04 4 P 0 3000 16.00 A 3000 D /s/Jeffrey Nau, Attorney-in-fact 2019-11-04